CGBio starts first clinical trial for next-generation stent for coronary artery

CGBio(CEO Hyun-Seung Yoo) announced after the Ministry of Food and Drug Safety(MOHW) approved the clinical trial plan of drug-eluting stent for coronary artery, Professor Hyo-Soo Kim’s research team at Seoul National University Hospital started the clinical trial for the first time and the procedure went successful.

As chosen for the project supervised by the MOHW to support clinical trials fo...